Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

SIOG 2014 /
Prostate Cancer Debate: Treatment strategies and options in castration-resistant prostate cancer

23rd - 25th Oct 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 31.10.14
Views: 5668

Prof Eleni Efstathiou, Prof Nicolas Mottet, Prof Noel Clarke, Prof Luís Costa

Prof Clarke (The Christie Hospital, Manchester, UK) chairs a discussion with Prof Efstathiou (MD Anderson Cancer Center, Houston, USA), Prof Mottet (University Hospital, Saint-Étienne, France),  and Prof Costa (University of Lisbon, Lisbon, Portugal) for ecancertv about the latest advancements in prostate cancer treatment.

They consider how the integration of concepts can inform the development of treatment strategies for advanced prostate cancer, looking at high-risk locally advanced disease, metastatic hormone sensitive disease, and the management of older patients.

This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).


Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation